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ORIGINAL ARTICLEMUS-2, a novel variant of the chromosome-encoded β-lactamase MUS-1,
from Myroides odoratimimusC. Al-Bayssari1,2, S. Kumar Gupta2, F. Dabboussi1, M. Hamze1 and J.-M. Rolain2
1) Laboratoire Microbiologie Santé et Environnement (LMSE), Centre Azm pour la Recherche en Biotechnologie et ses Applications, Ecole Doctorale de Sciences et
de Technologie, Université Libanaise, Tripoli, Libya and 2) Aix-Marseille Université, Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes
(URMITE), IHU Méditerranée Infection, Faculté de Médecine et de Pharmacie, Marseille, FranceAbstractThe aim of the present study was to investigate the molecular mechanism of carbapenem resistance of three imipenem-resistant isolates of
Myroides odoratimimus recovered from two livestock farms of cows and pigeons by rectal swab in Lebanon in January 2014. Investigation of
imipenem resistance of these isolates using the modified Hodge test, the EDTA test, the modified CarbaNP test and the matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry Ultraflex assay showed a carbapenemase activity due to the presence of a
chromosome-encoded β-lactamase MUS, verified by PCR. However amplification and sequencing of this chromosomal gene showed a
novel variant of it designated MUS-2 by the curators of the Lahey database of β-lactamases (http://www.lahey.org/Studies/webt.asp).
Cloning of the blaMUS-2 was performed, followed by protein expression in Escherichia coli TOP 10. Pulsed-field gel electrophoresis clearly
showed that the three isolates belonged to the same clone. This study reports a novel variant of the chromosome-encoded blaMUS-1
associated with carbapenem resistance in Myroides odoratimimus and shows that animals may represent a reservoir of bacteria harbouring
several variants of resistance genes.
New Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and
Infectious Diseases.
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E-mail: jean-marc.rolain@univ-amu.frIntroductionMyroides species, previously named as Flavobacterium odoratum,
are aerobic Gram-negative bacteria that can be found in envi-
ronmental sources such as soil and water, but are not residents
of the normal human microflora [1]. The genus Myroides
comprises two species, Myroides odoratus and Myroides odor-
atimimus [2]. Taking into consideration their role as causative
agents in human disease, both M. odoratimimus and M. odoratusNew Microbes and New Infections © 2015 The Authors. Published by El
This is an open access artiare seen rarely as opportunistic pathogens, causing infections in
severely immunocompromised patients and rarely, in immu-
nocompetent hosts [1,3]. Myroides odoratimimus strains have
been found to be responsible for urinary tract infections [4,5],
cellulitis [6,7] in immunocompromised patients, and also for
septic shock, pneumonia and soft-tissue infections [1,8] in
immunocompetent hosts. In addition, three outbreaks of
M. odoratimimus, two of urinary tract infections and the third of
central venous catheter-associated bloodstream infections due
to contaminated water, have been reported [2,4].
Antibiotic resistance patterns of Myroides strains show var-
iable susceptibility to β-lactams [5], with a conserved decreased
susceptibility to cephalosporins and carbapenems [9]. This
decreased susceptibility is the result of the production of a
chromosome-encoded β-lactamase MUS-1. This enzyme is a
member of the subclass B1 of metallo-β-lactamases and is
distantly related to other metalloenzymes, being most closelyNew Microbe and New Infect 2015; 7: 67–71
sevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases
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68 New Microbes and New Infections, Volume 7 Number C, September 2015 NMNIrelated to IND-1 from Chryseobacterium indologenes (42% amino
acid identity). However, phylogenic analysis showed that MUS-1
belongs to the same phylogenic lineage of subclass B1 enzymes
that groups the subclass B1 β-lactamases of Flavobacterium
species [9]. Here we report a novel variant, MUS-2, of the
chromosome-encoded β-lactamase MUS-1 from
M. odoratimimus isolated from livestock animals in Lebanon.Materials and methodsBacterial isolates
Three imipenem-resistant M. odoratimimus strains (32, 35a and
104b) were isolated from two livestock farms of cows and pi-
geons by rectal swabs (32: farm 1, cow; 35a: farm 1, pigeon; 104b:
farm 2, cow) in January 2014. These strains were collected
during a study that aimed to detect carbapenemase-encoding
genes in animals in Lebanon [10]. They were isolated on Mac-
Conkey agar supplemented by ertapenem (1 mg/L), from alive
and non-sick animals without contact with any other animals.
Strains were sub-cultured on trypticase soy agar plates at 37°C
for 18–24 h and identification was confirmed by matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry
(MALDI-TOF/MS) (Microflex™; Bruker Daltonics, Bremen,
Germany) with FLEXCONTROL software (Bruker Daltonics).
Antibiotic susceptibility testing
Antibiotic susceptibility testing was determined on Müller–
Hinton agar by standard disc diffusion method as recommended
by the European Committee on Antimicrobial Susceptibility
Testing (EUCAST; www.eucast.org). Seventeen antibiotics
were tested, including ticarcillin, ticarcillin-clavulanic acid,
piperacillin, piperacillin-tazobactam, ceftazidime, cefotaxime,
cefepime, aztreonam, amikacin, tobramycin, gentamicin, cipro-
floxacin, rifampicin, ertapenem, meropenem, imipenem and
colistin (Bio-Rad, Marnes-la-Coquette, France). The MIC for
imipenem was determined using the Etest method (bioMérieux,
La Balmes les Grottes, France) and the result was interpreted
according to the EUCAST breakpoint for Enterobacteriaceae
(susceptible if MIC  2 mg/L)
Phenotypic and molecular detection of
carbapenemases
Isolates were screened for carbapenemase production using the
modified Hodge test, the EDTA, the Modified CarbaNP test as
previously described [11–13] and also by MALDI-TOF MS
Ultraflex assay [14]. Screening for class A, B and D carbape-
nemases was carried out using PCR according to previous
protocols and previously described primers including for blaVIM,
blaIMP, blaNDM-1, blaKPC and all the blaOXA variants [15–20]. InNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/liceaddition, amplification of the chromosomal MUS gene was
performed using primers designed in this study (MUS-F/R 50-
CGTTAGGCACACCAGAAGAA-3’/30-TCCACACCATTCT-
GAGCGTA-50). These primers were designed outside the re-
gion containing the blaMUS-1 located on the chromosome of a
random M. odoratimimus genome deposited in GenBank. PCR
products were purified and sequenced using the Big dye
terminator chemistry on an ABI 3730 automated sequencer
(Applied Biosystems, Foster City, CA, USA). The sequences
obtained were analysed using BLASTN and BLASTP against the
NCBI database (www.ncbi.nlm.nih.gov).
Cloning of the MUS-2 gene
The full length of the blaMUS-2 from M. odoratimimus was
amplified using Herculase II Fusion Enzyme with dNTPs Combo
(Agilent Technologies, Santa Clara, CA, USA) with primer
MUS_F/MUS_R. The gene was then cloned into the high-copy-
number plasmid pCR-BluntII-TOPO using the Zero Blunt
TOPO PCR cloning kit (Invitrogen, Calrsbad, CA, USA). The
resulting plasmid pTOPO-MUS-2 was transformed into TOP10
Electrocomp™ Escherichia coli. Transformants were selected on
Luria–Bertani agar supplemented with 100 mg/L of kanamycin;
the presence of the insert was confirmed by PCR. The antibi-
otic resistance profile of the TOP10 E. coli containing pTOPO-
MUS vector was then determined.
Molecular strain typing
The three isolates were typed by the pulsed-field gel electro-
phoresis (PFGE) method as previously described [4]. The DNA
was digested with SmaI restriction enzyme and the fragments of
DNA were separated using a GenePath system (Bio-Rad). The
running conditions were 6 V/cm at 14°C for 20 h.ResultsDuring a previous study that was aiming to detect carbapene-
mases encoding genes in animals in livestock farms in Lebanon
[10], three isolates of M. odoratimimus were isolated and were
studied separately. These isolates were obtained after culture of
animal faeces in MacConkey agar supplemented with ertape-
nem (1 mg/L) and were identified by MALDI-TOF MS as
M. odoratimimus (score: 2.439). The results of antibiotic sus-
ceptibility testing revealed that the isolates were resistant to
almost all antibiotics, including β-lactams, aminoglycosides and
colistin but remain susceptible to sulfamethoxazole-
trimethroprim, rifampicin and fluoroquinolones (Table 1). In
addition, all the isolates showed resistance to carbapenems with
MIC for imipenem at 8 mg/L. The isolates were then analysed
via the modified Hodge test, the MALDI-TOF MS UltraflexEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 7, 67–71
nses/by-nc-nd/4.0/)
TABLE 1. Antimicrobial susceptibility testing of the three Myroides isolates
TIC PRL TIM TPZ CAZ FEP CTX ETP MEM IPM TOB AMK GEN CIP ATM RA SXT CT
MO_32 R R R R R R R R R R R R R I R S S R
MO_35a R R R R R R R R R R R R R I R S S R
MO_104b R R R R R R R R R R R R R I R S S R
MO, Myroides odoratimimus; TIC, ticarcillin; PRL, piperacillin; TIM, ticarcillin-clavulanic acid; TPZ, piperacillin-Tazobactam; CAZ, ceftazidime; FEP, cefepime; CTX, cefotaxime; ETP,
ertapenem; MEM, meropenem; IPM, imipenem; TOB, tobramycin; AMK, amikacin; GEN, gentamicin; CIP, ciprofloxacin; ATM, aztreonam; RA, rifampicin; SXT, sulfamethoxazole-
trimethroprim; CT, colistin; R, resistant; I, intermediate; S, susceptible.
FIG. 1. Amino acid sequence alignment between the MUS-1 and MUS-2 proteins.
TABLE 2. MICs of β-lactams for Myroides odoratimimus 35a,
TOP10 Escherichia coli and TOP10 E. coli pTOPO-MUS-2
Substratea
MIC (μg/mL)
M. odoratimimus 35a
TOP10 E. coli
pTOPO-MUS-2 TOP10 E. coli
Amoxicillin 32 128 2
Amoxicillin-CLA 32 128 2
Ticarcillin 256 256 2
Piperacillin 128 8 2
Piperacillin-TZB 24 8 1
Cephalotin 128 8 2
Cefoxitin 32 4 2
Moxalactam 32 0.064 0.19
Cefotaxime 32 0.094 0.047
Cefuroxime 128 6 1
Ceftazidime 128 0.38 0.064
Cefepime 32 0.064 0.064
Cefpirone 32 0.064 0.064
Aztreonam 64 0.064 0.064
Imipenem 8 0.38 0.064
Meropenem 4 0.38 0.064
aCLA, clavulanic acid at 2 μg/mL; TZB, tazobactam at 4 μg/mL.
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they were all positive on the modified Hodge test, EDTA-disc
and modified CarbaNP test positive. In addition, the MALDI-
TOF MS Ultraflex assay was positive for all of them—
suggesting a carbapenemase production, more specifically a
metallo-β-lactamase as the EDTA test was positive. Screening
for carbapenemase-encoding genes by PCR using carbapene-
mase gene primers showed a negative result for blaVIM, blaIMP,
blaNDM-1, blaKPC and all the blaOXA variants. However the
chromosomal MUS gene was amplified using primers MUS-F/R.
Sequencing of the chromosomal MUS gene of the three
isolates and nucleotide alignment between the blaMUS-1 and the
new blaMUS sequence showed some differences. The blaMUS-2
differed from blaMUS-1 due to substitution in nucleotides at
positions 69 (A/G), 525 (A/G), 171 (C/T), 177 (C/T),
397 (C/T), 671 (C/T), 179 (T/C), 514 (T/C) and 675
(C/G), resulting in a different protein MUS-2 that differ from
MUS-1 protein due to substitution of amino acid at position 60
(Valine/Alanine), 133 (Histidine/Tyrosine) and 224
(Threonine/Isoleucine) (Fig. 1). The percentage of homology
between the two amino acid sequences was 98.78.
The new enzyme variant was designated MUS-2 by the cu-
rators of the Lahey database of β-lactamases (http://www.lahey.
org/Studies/webt.asp) and deposited in GenBank under acces-
sion number KP658209.
Cloning of the BlaMUS-2 successfully gave plasmids harbouring
this gene; these plasmids were transformed into TOP10 Elec-
trocomp™ E. coli. The presence of the insert was verified by
PCR. MIC values of β-lactams for the E. coli TOP10 strain,
which harbours recombinant plasmid pTOPO-MUS-2, showedNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on beha
This is an open access artithat the bacteria was resistant to amoxicillin and ticarcillin and
had a reduced susceptibility to piperacillin, in addition it showed
an increased resistance to extended-spectrum cephalosporins
and carbapenems by at least four-fold of MIC (Table 2).
Finally, PFGE analysis showed that the three strains of
M. odoratimimus were genetically clonal since their PFGE pro-
files were similar (Fig. 2).DiscussionTo date, infections caused by M. odoratimimus in immuno-
compromised and immunocompetent hosts had been rarelylf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 7, 67–71
cle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
FIG. 2. Pulsed-field gel electrophoresis
of SmaI DNA restriction digests of the
three Myroides odoratimimus isolates.
70 New Microbes and New Infections, Volume 7 Number C, September 2015 NMNIreported [1,2,4–8]. The fact that this bacterium might cause
infection in immunocompetent hosts is a real health problem
because it is resistant to β-lactams including carbapenems,
aminoglycoside but also to colistin. Biochemical detection of
β-lactamases in clinical strains of Myroides spp. (formerly
F. odoratum) was performed in 1985 by Sato et al. [21], but the
molecular characteristics of β-lactamase were not reported.
We would have to wait until 2002 when Mammeri et al. bio-
chemically and genetically characterized β-lactamases
expressed in M. odoratimimus and M. odoratus [9]. In fact,
M. odoratimimus species produce chromosomal MUS-1 β-lac-
tamase, which belongs to the subclass B1 of Ambler classifica-
tion, and their antibiotic resistance patterns show a constant
decreased susceptibility to imipenem [9].The β-lactamase pro-
duced by the three M. odoratimimus isolates in our study shared
98.78% amino acid identity with the known MUS-1 protein. At
the present time, each bacterial species of the Flavobacteriaceae
family that has been investigated for β-lactamase characteriza-
tion produces a subclass B1 metalloenzyme [9]. Our study
confirms a previous study performed on M. odoratimimus spe-
cies; however, here we report a new variant of this enzyme in
Lebanon. PFGE analysis showed that these isolates belong to
the same clone because they had the same PFGE profile. This
confirms that contamination between farms has occurred and
precautions should be established to limit the emergence of this
clone in livestock farms because that could be a source of
human infection.
Taking into consideration the biochemical criteria estab-
lished by Rasmussen and Bush to classify metallo-β-lactamases
[22], MUS-1 and most probably MUS-2 belong to functional
subgroup 3a, as their catalytic efficiencies for penicillins are at
least 60% of that for imipenem [9]. However, these data are
discrepant with those from Rasmussen and Bush [22], whoNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licementioned that a metallo-β-lactamase produced by F. odoratum
strain belongs to subgroup 3b, which groups true carbapenem-
hydrolysing β-lactamases. Regarding this conflict, it is very
difficult to estimate the exact role of either MUS-1 or MUS-2 in
the intrinsic β-lactam resistance of M. odoratimimus because the
metalloenzymes expressed in E. coli give much lower levels of
resistance to β-lactams than those seen in the original pro-
ducers as seen in the TOP10 E. coli after cloning.
Finally, it remains unknown if these bacteria could be a
source of such a variety of metalloenzymes. The most serious
finding is that animals could be a reservoir for such genes and
are a source of new and/or emerging multidrug-resistant bac-
teria and due to possible links with animals, humans may have
high risk factors for colonization/infection with such bacteria.
In conclusion, we report a novel variant of the chromosome-
encoded β-lactamase MUS-1 that has been designated MUS-2
from M. odoratimimus isolates from livestock animals in
Lebanon.GenBank accession numberThe full sequence of the BlaMUS-2 described in this study is
deposited in the GenBank database with accession no.
KP658209.FundingThis work was supported by AZM research centre for
biotechnology and its application, Lebanese University, the
National Council for Scientific Research, Lebanon, the IHU
Méditerranée Infection and the French CNRS.European Society of Clinical Microbiology and Infectious Diseases, NMNI, 7, 67–71
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